Target intelligence / Profile preview

Gliadin and related gluten prolamins

Molecular classification
Prolamin, Plant storage protein, Dietary antigen
01

Overview

Gliadin and related gluten prolamins are a group of alcohol-soluble storage proteins found in wheat, barley, and rye that are characterized by high proline and glutamine content (Source: UniProt). These proteins are resistant to complete digestion by human gastrointestinal proteases, leaving behind large, immunogenic peptides such as the 33-mer fragment (Source: PubMed, PMID: 12364798). In individuals with Celiac disease, these peptides cross the intestinal barrier and trigger an inflammatory immune response mediated by T-cells, leading to villous atrophy and malabsorption (Source: NIH, NIDDK). As a therapeutic target, gliadin is addressed through various strategies including enzymatic degradation by oral proteases like latiglutenase, which cleaves the protein into non-toxic fragments (Source: ClinicalTrials.gov). Other approaches include the use of sequestering polymers to prevent gluten absorption or nanoparticles designed to induce immune tolerance to gliadin antigens (Source: Takeda Pharmaceuticals).

Other names
GlutenProlaminsWheat gliadinHordein (Barley)Secalin (Rye)Avenin (Oats)Wheat storage protein
02

Mechanism of action

Proteolytic degradation of immunogenic peptides, non-absorbable sequestration, and induction of immune tolerance.

03

Biological functions

Seed storage proteinNutrient storage for germinationImmune trigger in Celiac disease
04

Disease associations

Celiac diseaseNon-celiac gluten sensitivityDermatitis herpetiformisGluten ataxiaWheat allergy
05

Safety considerations

Incomplete degradation of immunogenic epitopesGastric stability of therapeutic enzymesPotential for allergic reactions to microbial enzymesEfficacy in the presence of high gluten loads
06

Interacting drugs

Latiglutenase (IMGX003/ALV003)

3 more in the full profile.

07

Biomarkers

Anti-deamidated gliadin peptide (DGP) antibodiesAnti-tissue transglutaminase (tTG) antibodiesAnti-gliadin antibodies (AGA)HLA-DQ2/DQ8 genotyping

Beyond the preview

Go deeper on Gliadin and related gluten prolamins.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Gliadin and related gluten prolamins.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call